Neuronetics Inc
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pul… Read more
Neuronetics Inc (STIM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.025x
Based on the latest financial reports, Neuronetics Inc (STIM) has a cash flow conversion efficiency ratio of -0.025x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-785.00K) by net assets ($31.36 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Neuronetics Inc - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Neuronetics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Neuronetics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Neuronetics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Deoleo S.A
PINK:SOSCF
|
0.002x |
|
Cayson Acquisition Corp
NASDAQ:CAPNU
|
-0.002x |
|
Reeder Teknoloji Sanayi ve Ticaret Anonim Sirketi
IS:REEDR
|
-0.030x |
|
Laurion Mineral Exploration Inc
PINK:LMEFF
|
-0.278x |
|
Raphas Co. Ltd
KQ:214260
|
-0.014x |
|
Byuksan Corp
KO:007210
|
0.031x |
|
Woosu AMS Co.Ltd
KQ:066590
|
0.066x |
|
Jaiprakash Associates Limited
NSE:JPASSOCIAT
|
0.066x |
Annual Cash Flow Conversion Efficiency for Neuronetics Inc (2016–2024)
The table below shows the annual cash flow conversion efficiency of Neuronetics Inc from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $31.80 Million | $-31.00 Million | -0.975x | -4.03% |
| 2023-12-31 | $34.19 Million | $-32.04 Million | -0.937x | -73.94% |
| 2022-12-31 | $57.06 Million | $-30.74 Million | -0.539x | -63.97% |
| 2021-12-31 | $85.17 Million | $-27.98 Million | -0.329x | +70.50% |
| 2020-12-31 | $25.49 Million | $-28.39 Million | -1.114x | -74.82% |
| 2019-12-31 | $47.85 Million | $-30.48 Million | -0.637x | -119.78% |
| 2018-12-31 | $71.04 Million | $-20.59 Million | -0.290x | -601.07% |
| 2017-12-31 | $-192.65 Million | $-11.14 Million | 0.058x | +19.96% |
| 2016-12-31 | $-177.12 Million | $-8.54 Million | 0.048x | -- |